CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00005183
NCT00005183N/ACompleted
CompareCT.gov

Apolipoprotein A-I Gene Polymorphism and Atherosclerosis

Tufts University·observational·Posted May 26, 2000·Updated Dec 21, 2017

In Brief

An observational study for Coronary Arteriosclerosis and 3 related conditions. Completed.

Detailed Summary

To further define the linkage of the Apo A-I gene polymorphism to genetic high density lipoprotein (HDL) deficiency and premature coronary artery disease. Also, to utilize this gene marker to define the prevalence of genetic HDL deficiency in patients with premature coronary disease and to determine the relative risk of premature coronary disease associated with the Apo A-I gene polymorphism.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Arteriosclerosis, Cardiovascular Diseases, Heart Diseases, Atherosclerosis
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)

Timeline

N/ACompletedFinished
1985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 26, 2000
Enrollment StartDec 1, 1985
Study CompletionNov 1, 1988
TodayJul 2, 2026
Posted 26.1 years ago